Incannex Healthcare Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Incannex Healthcare Inc
Access all reports
Incannex Healthcare Inc. is a clinical-stage pharmaceutical company focused on developing medicinal cannabis and psychedelic pharmaceutical products. The company is engaged in the research, development, and commercialization of therapies aimed at addressing a range of medical conditions. These include obstructive sleep apnea (OSA), traumatic brain injury (TBI), lung inflammation, rheumatoid arthritis, inflammatory bowel disease, anxiety, addiction, and chronic pain. Incannex Healthcare's product portfolio consists of both cannabinoid-based formulations and novel psychedelic therapies, which are in various stages of clinical development. The company is headquartered in Sydney, Australia, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
IXHL
Country
🇺🇸 United States